Characteristic | Fallers (n=69) | Non-fallers (n=32) | Test | p Value |
---|---|---|---|---|
Data are median with range or absolute number with percentages. **p<0.01. 1, independent samples t test; 2, χ2 test; 3, Mann-Whitney U test. | ||||
Age (years) | 75 (54–92) | 75 (60–92) | 1 | 0.526 |
Male sex | 37 (53.6%) | 13 (40.6%) | 2 | 0.224 |
Duration of symptoms (years) | 6 (1–37) | 4.5 (1–11) | 3 | 0.006** |
In long term care (years) | 6 (8.7%) | 1 (3.1%) | 2 | 0.427 |
Number of falls in previous year | 3 (0–500) | 0 (0–5) | 3 | <0.001** |
History of any fall | 50 (72.5%) | 12 (37.5%) | 2 | 0.003** |
History of recurrent falls | 43 (62.3%) | 5 (15.6%) | 2 | <0.001** |
Levodopa dose (mg) | 400 (0–1250) | 375 (0–800) | 1 | 0.102 |
Dopamine agonist use | 10 (14.5%) | 8 (25%) | 2 | 0.199 |
Benzodiazepine use | 6 (8.7%) | 3 (9.4%) | 2 | 0.911 |
Polypharmacy | 7 (10.1%) | 5 (15.6%) | 2 | 0.428 |